Breast cancer: Why it's difficult to treat and what new approaches are on the horizon
Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It is also ...
Oxford Mail4h
Oxford researchers discover why IBD treatment doesn't always work
Oxford researchers have discovered why some patients benefit from the most commonly used advanced therapy in autoimmune diseases and some do not.
AllAfrica.com4h
Africa: Breast Cancer - Why It's Difficult to Treat and What New Approaches Are On the Horizon
Analysis - Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It is also particularly challenging to treat. Physiologist Anna-Mart ...
Key receptor reveals how gut cells detect harmful invaders
The human gut is home to helpful microbes, called the microbiota, who produce molecules known as metabolites. These ...
eLife6h
Membrane potential modulates ERK activity and cell proliferation
Department of Physiology, Division of Life Science, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan ...
SonoThera to Present at ASN Kidney Week 2024 Demonstrating the Potential of Novel Nonviral Ultrasound-Mediated Gene Therapy Delivery Platform
SonoThera to Present at ASN Kidney Week 2024 Demonstrating the Potential of Novel Nonviral Ultrasound-Mediated Gene Therapy ...
birmingham.ac.uk8h
Study charts course for next generation of drug targets in autoimmune diseases
In a world first, researchers have mapped the cellular dynamics following treatment with the most commonly used advanced ...